Home business company profiles reviews & industry history since 1999

USANA Reports Second Quarter Sales of 223 Million Dollars and Net Loss on Impairment


SALT LAKE CITY, Utah -- August 4, 2026

USANA Health Sciences reported second-quarter 2026 net sales of 223 million dollars, down 5% from 236 million dollars a year earlier. The company posted a net loss of 21.4 million dollars, or 1.16 dollars per diluted share, which included an estimated preliminary non-cash impairment charge of 29.1 million dollars, compared with net earnings of 9.7 million dollars, or 0.52 dollars per diluted share, a year earlier.

Adjusted diluted EPS was a loss of 0.07 dollars, and adjusted EBITDA was 27.8 million dollars versus 30.5 million dollars. Core Nutritional Active Customers were 384,000, down from 418,000.

USANA said foreign currency provided a favorable sales impact of about 6 million dollars, or 3%, in the quarter.

More USANA Health Sciences news

USANA Adds New Bonuses in Compensation Plan Update

USANA has updated its brand story and added new sales bonuses, milestone bonuses and targeted leadership bonuses for its Brand Partners, aimed at helping them earn sooner and...